Investor Relations

SEC Filings

Document Details

Form
Filing Date
Feb 24, 2021
Document Date
Feb 22, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.